ACVR2A Antibody / Activin receptor type 2A, 0.08 ml

ACVR2A is a receptor protein that belongs to the TGF-beta superfamily, which is known for its role in controlling cell growth, differentiation, and development. Studies have shown that mutations in the ACVR2A gene can lead to a variety of health conditions, including certain types of cancer and developmental disorders. One of the most intriguing aspects of ACVR2A is its potential as a therapeutic target. By developing drugs that can modulate the activity of ACVR2A, researchers may be able to treat a range of diseases, from cancer to muscular dystrophy. Recent studies have even suggested that targeting ACVR2A could help improve outcomes for patients with certain types of cancer.